R&D at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Utah Medical Products's R&D?
- Utah Medical Products (UTMD) reported R&D of $154K in Q1 2026.
- How has Utah Medical Products's R&D changed year-over-year?
- Utah Medical Products's R&D decreased by 0.0% year-over-year, from $154K to $154K.
- What is the long-term trend for Utah Medical Products's R&D?
- Over 4 years (2021 to 2025), Utah Medical Products's R&D has grown at a 6.2% compound annual growth rate (CAGR), from $526K to $668K.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.